These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17489669)

  • 1. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.
    Kakar P; Lip GY
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):441-50. PubMed ID: 17489669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is hypertension a prothrombotic state?
    Varughese GI; Lip GY
    Curr Hypertens Rep; 2005 Jun; 7(3):168-73. PubMed ID: 15913489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction and the promise of ACE inhibitors.
    Rockett JL
    Am J Nurs; 1999 Oct; 99(10):44-9; quiz 50. PubMed ID: 10542849
    [No Abstract]   [Full Text] [Related]  

  • 4. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and preventive therapy of age-related macular degeneration through the beneficial effect of treatment of endothelial dysfunction].
    Fischer T
    Orv Hetil; 2006 Dec; 147(51):2465-8. PubMed ID: 17378165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms.
    Kapur V; Schwarz ER
    Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of target organ damage in hypertension.
    Karpha M; Lip GV
    Minerva Cardioangiol; 2006 Aug; 54(4):417-29. PubMed ID: 17016413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial dysfunction: pathophysiology, diagnosis and prognosis].
    Münzel T
    Dtsch Med Wochenschr; 2008 Nov; 133(47):2465-70. PubMed ID: 19006047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.
    Zoccali C
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S61-3. PubMed ID: 16565249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of renin-angiotensin system in prothrombotic state in essential hypertension.
    Remková A; Remko M
    Physiol Res; 2010; 59(1):13-23. PubMed ID: 19249905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of ET-1-induced endothelial dysfunction.
    Iglarz M; Clozel M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):621-8. PubMed ID: 18091577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction, platelet activation, thrombogenesis and fibrinolysis in patients with hypertensive crisis.
    van den Born BJ; Löwenberg EC; van der Hoeven NV; de Laat B; Meijers JC; Levi M; van Montfrans GA
    J Hypertens; 2011 May; 29(5):922-7. PubMed ID: 21372741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of endothelial dysfunction.
    Freestone B; Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):557-71. PubMed ID: 20397829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension.
    Perticone F; Maio R; Tripepi G; Sciacqua A; Mallamaci F; Zoccali C
    J Nephrol; 2007; 20 Suppl 12():S56-62. PubMed ID: 18050145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
    Zimmermann N; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients with hypertension receive antithrombotic therapy?
    Lip GY; Edmunds E; Beevers DG
    J Intern Med; 2001 Mar; 249(3):205-14. PubMed ID: 11285041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence.
    Bautista LE
    J Hum Hypertens; 2003 Apr; 17(4):223-30. PubMed ID: 12692566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and the prothrombotic state.
    Lip GY
    J Hum Hypertens; 2000; 14(10-11):687-90. PubMed ID: 11095159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.